Anatara Lifesciences Ltd

Research Anatara Lifesciences Ltd (ANR) on Bullrun: market cap AUD 3.16M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerANR
• ExchangeAU
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyAUD
• Market capAUD 3.16M
• Financial periodFY2025
• RevenueAUD 970.00K
• Revenue growth51.6%
• Net income-AUD 1.95M
• Free cash flow-AUD 2.27M
• Gross margin-64.9%

Valuation Snapshot

latest market cap is AUD 3.16M.

About Anatara Lifesciences Ltd

Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in Australia. The company's products include Gastrointestinal ReProgramming, a multi-component, multi-coated medicine designed to address underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease; and Detach for the treatment of diarrhea in piglets.

Frequently asked questions

What is Anatara Lifesciences Ltd's market cap?

Anatara Lifesciences Ltd's market capitalization is AUD 3.16M.

What does Anatara Lifesciences Ltd do?

Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in Australia.